UCBJY:OTCMKTS
UCB Unsponsored Belgium ADR
114,46 US$
arrow_downward
-0,87%(-1,01) 1K
16-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoUCBJY tikeri uchun statistika yaratilmoqda...
Ochish
114,95 US$
Yuqori
115,28 US$
Past
114,23 US$
Bozor kapitali
39,39 mlrd
Oʻrtacha hajm
53,31 ming
Hajmi
70,57 ming
52 haftalik eng yuqori
168,76 US$
52 haftalik eng past
110,55 US$
Beta
0,57
Muomaladagi aksiyalar
389,01 mln
Xodimlar soni
9 ming
Ochish
114,95 US$
Yuqori
115,28 US$
Past
114,23 US$
Bozor kapitali
39,39 mlrd
Oʻrtacha hajm
53,31 ming
Hajmi
70,57 ming
52 haftalik eng yuqori
168,76 US$
52 haftalik eng past
110,55 US$
Beta
0,57
Muomaladagi aksiyalar
389,01 mln
Xodimlar soni
9 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
2 soat oldin
UCB wins FDA approval for ZILBRYSQ autoinjector and UCB stock costs EUR 203.00
ad-hoc-news.de
·
1 kun oldin
UCB launches Wear It Out: what it means for UCB stock
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
UCB Unsponsored Belgium ADR haqida
CEOJean-Christophe Tellier
Xodimlar soni9 ming
Asos solingan18-yan, 1928
Bosh ofislar-
Sektor-
Veb-saytucb.com